The effect of reiki on pain in women undergoing non-emergency caesarean sections

ISRCTN ISRCTN79265996
DOI https://doi.org/10.1186/ISRCTN79265996
Secondary identifying numbers REB#-08-030
Submission date
14/04/2009
Registration date
27/05/2009
Last edited
30/12/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Gideon Koren
Scientific

Professor of Pediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics
Clinician-Scientist
The Hospital for Sick Children
Division of Clinical Pharmacology, Rm 8232
555 University Ave
Toronto
M5G 1X8
Canada

Phone +1 416 813 1500 ext. 5781
Email gkoren@sickkids.ca

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe effect of reiki on pain in women who will undergo non-emergency caesarean sections and the effect of genetic variation on the use of codeine: a randomised controlled trial
Study acronymREPA
Study objectivesCan reiki reduce pain after caesarean section by more than 25%?
Ethics approval(s)St. Michael's Hospital Ethics Review Board approved on the 12th May 2008 (ref: 08-030)
Health condition(s) or problem(s) studiedPain levels after caesarean section
Intervention1. Control group: usual care
2. Reiki Group: usual care plus 20 minutes of Remote Reiki

Duration: three days while in the hospital.
Intervention typeOther
Primary outcome measureVisual Analogue Scale for pain in movement, at day 1, day 2 and day 3 (amended as of 10/08/09; initial outcome timepoints were 'after 72 hours in hospital').
Secondary outcome measures1. Visual Analogue Scale for pain (in rest)
2. Pain medication (codeine consumption/kg)
3. Return time to normal activities

All measured at day 1, day 2 and day 3 (amended as of 10/08/09; initial outcome timepoints were 'after 72 hours in hospital').
Overall study start date30/06/2008
Completion date30/04/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexFemale
Target number of participants80
Total final enrolment80
Key inclusion criteria1. Informed consent
2. Planned caesarean section
3. Pregnant women aged 18 - 48 years
Key exclusion criteriaDoes not meet with inclusion criteria
Date of first enrolment30/06/2008
Date of final enrolment30/04/2009

Locations

Countries of recruitment

  • Canada

Study participating centre

Professor of Pediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics
Toronto
M5G 1X8
Canada

Sponsor information

The Hospital for Sick Children (Canada)
Hospital/treatment centre

c/o Gideon Koren
Professor of Pediatrics, Pharmacology, Pharmacy, Medicine and Medical Genetics
Clinician-Scientist
Division of Clinical Pharmacology, Rm 8232
555 University Ave
Toronto
M5G 1X8
Canada

Website http://www.sickkids.ca/
ROR logo "ROR" https://ror.org/057q4rt57

Funders

Funder type

Other

Investigator initiated and funded (Canada)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 26/02/2011 30/12/2020 Yes No

Editorial Notes

30/12/2020: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.